Trial intelligence / Profile preview

Ocular effects of oral azithromycin in adolescents with pharyngitis/tonsillitis

2016-001119-19Phase 2

Sponsor
Pfizer
Start
Apr 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of azithromycin in pharyngitis and tonsillitis, sponsored by Pfizer. Primary endpoint: Clinically significant worsening in ocular safety assessments.

02

Drugs

azithromycin
03

Conditions

pharyngitistonsillitis

Beyond the preview

Go deeper on 2016-001119-19.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-001119-19.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call